Area of research
Molecular Biology · Pulmonary and Respiratory Medicine
Research interest
Research interests include RNA modifications and cancer, Fibroblast Growth Factor Research, RNA regulation and disease, and Gastric Cancer Management and Outcomes.
A deep-learning model for quantifying circulating tumour DNA from the density distribution of DNA-fragment lengths
Spatial profiling of patient-matched HER2 positive gastric cancer reveals resistance mechanisms to targeted therapy
Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with gastric cancer
Spatially Resolved Niche and Tumor Microenvironmental Alterations in Gastric Cancer Peritoneal Metastases
Phase I PIANO trial—PIPAC-oxaliplatin and systemic nivolumab combination for gastric cancer peritoneal metastases: clinical and translational outcomes
Margetuximab plus pembrolizumab in patients with previously treated, HER2-positive gastro-oesophageal adenocarcinoma (CP-MGAH22–05): a single-arm, phase 1b–2 trial
Molecular Characterization and Clinical Outcomes in RET-Rearranged NSCLC
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic gastric cancer: a JSMO–ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS
Phase 1b/2 study of margetuximab (M) plus pembrolizumab (P) in advanced HER2+ gastroesophageal junction (GEJ) or gastric (G) adenocarcinoma (GEA).
Phase Ib study of BGJ398 in combination with BYL719 in patients (pts) with select advanced solid tumors.